Pages that link to "Q45758432"

The following pages link to Contributions of Antibody and T Cell Subsets to Protection Elicited by Immunization with a Replication-Defective Mutant of Herpes Simplex Virus Type 1 (Q45758432):

Displaying 34 items.

• Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector (Q26247032) (← links)
• Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle. (Q33820864) (← links)
• Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain. (Q33826884) (← links)
• Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. (Q33837275) (← links)
• B7 Costimulation Molecules Encoded by Replication-Defective, vhs-Deficient HSV-1 Improve Vaccine-Induced Protection against Corneal Disease (Q33985984) (← links)
• The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice (Q34150713) (← links)
• Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity (Q34335296) (← links)
• Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection (Q34335569) (← links)
• Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1. (Q34341979) (← links)
• The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon (Q34344812) (← links)
• Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model (Q34447379) (← links)
• Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models (Q35271194) (← links)
• Development of prophylactic vaccines for genital and neonatal herpes (Q35623334) (← links)
• Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1. (Q35665813) (← links)
• Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine γ-herpesvirus-68 (Q35685590) (← links)
• Immune regulation of viral infection and vice versa (Q36232751) (← links)
• Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes (Q36570266) (← links)
• Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. (Q37059943) (← links)
• Effective vaccination against long-term gammaherpesvirus latency (Q39700306) (← links)
• A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells (Q40263261) (← links)
• BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice (Q40729197) (← links)
• Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency (Q40909739) (← links)
• Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells (Q41495016) (← links)
• Attenuated phenotypes and analysis of a herpes simplex virus 1 strain with partial deletion of the UL7, UL41 and LAT genes. (Q41925774) (← links)
• Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion (Q44483646) (← links)
• Analysis of the Protective Immunity Induced by Herpes Simplex Virus 1 Strain M3 with an Attenuated Phenotype Due to Mutations in the Viral ul7, ul41, and LAT Genes (Q45072015) (← links)
• Myeloid C3 Determines Induction of Humoral Responses to Peripheral Herpes Simplex Virus Infection (Q45710439) (← links)
• Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus (Q45723117) (← links)
• Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice. (Q45746812) (← links)
• Brain resistance to HSV-1 encephalitis in a mouse model. (Q48585884) (← links)
• Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease (Q59358017) (← links)
• Herpes simplex type 2 infections--an update (Q73874722) (← links)
• Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia (Q77402597) (← links)
• The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27 (Q85296339) (← links)